Cargando…

CART序贯二次异基因造血干细胞移植治疗移植后复发急性B淋巴细胞白血病41例临床分析

OBJECTIVE: To study the clinical efficacy of chimeric antigen receptor T-cell(CART)treatment followed by a second allogeneic hematopoietic stem cell transplantation(allo-HSCT)in patients with B-cell acute lymphoblastic leukemia (ALL) who relapsed following the first HSCT. METHODS: Retrospective anal...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120115/
https://www.ncbi.nlm.nih.gov/pubmed/33979977
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.04.009